Raymond G G, Reed M T, Teagarden J R, Story K, Geberbauer C W
College of Pharmacy, University of New Mexico, Albuquerque 87131.
Am J Hosp Pharm. 1988 Dec;45(12):2513-7.
The stability of procainamide hydrochloride in neutralized 5% dextrose injection was studied. Sixty-four admixtures were prepared by adding either 2 mL (for 0.4% admixtures) or 4 mL (for 0.8% admixtures) of procainamide hydrochloride to 250 mL of 5% dextrose injection in plastic containers. The pH of 32 of these admixtures (16 of each type) was adjusted to 7.5. These 32 admixtures represented the neutralized group, and the remaining 32 represented the control group. The admixtures were stored at either 23-25 degrees C (room temperature) or 5 degrees C (refrigeration) for 24 hours. Procainamide hydrochloride concentrations in each sample were determined by high-performance liquid chromatography immediately after the admixtures were prepared and at various intervals during storage. Procainamide concentrations decreased over time in 5% dextrose injection. The decrease was significantly less for admixtures in neutralized 5% dextrose injection, those stored under refrigeration, and those with an 0.8% concentration of drug. Decreases in procainamide hydrochloride concentrations in the control admixtures might have been caused by procainamide-dextrose complexation. Initial concentrations of procainamide hydrochloride in 5% dextrose injection can be adequately maintained over a 24-hour storage period by neutralizing the 5% dextrose injection or storing the admixture at 5 degrees C. However, because it is impractical to maintain the necessary temperature condition during a 24-hour infusion, neutralization might be the most viable alternative when extended stability of procainamide hydrochloride in 5% dextrose injection is required.
研究了盐酸普鲁卡因胺在中和后的5%葡萄糖注射液中的稳定性。通过向塑料容器中250 mL的5%葡萄糖注射液中加入2 mL(用于0.4%混合液)或4 mL(用于0.8%混合液)盐酸普鲁卡因胺来制备64种混合液。将其中32种混合液(每种类型16种)的pH值调至7.5。这32种混合液代表中和组,其余32种代表对照组。混合液在23 - 25℃(室温)或5℃(冷藏)下储存24小时。在混合液制备后立即以及储存期间的不同时间间隔,通过高效液相色谱法测定每个样品中盐酸普鲁卡因胺的浓度。在5%葡萄糖注射液中,盐酸普鲁卡因胺浓度随时间降低。在中和后的5%葡萄糖注射液中的混合液、冷藏储存的混合液以及药物浓度为0.8%的混合液中,浓度降低明显较少。对照混合液中盐酸普鲁卡因胺浓度的降低可能是由普鲁卡因胺 - 葡萄糖络合作用引起的。通过中和5%葡萄糖注射液或将混合液储存在温度为5℃的条件下,5%葡萄糖注射液中盐酸普鲁卡因胺的初始浓度在24小时储存期内可得到充分维持。然而,由于在24小时输液过程中维持必要的温度条件不切实际,当需要盐酸普鲁卡因胺在5%葡萄糖注射液中具有延长的稳定性时,中和可能是最可行的选择。